Identifying metabolically healthy but obese individuals in sedentary postmenopausal women

Obesity

Volumn 18, Issue 5, 2010, Pages 911-917

  Messier, Virginie ^a,b   Karelis, Antony D ^c   Prud'Homme, Denis ^d   Primeau, Vanessa ^e   Brochu, Martin ^f,g   Rabasa Lhoret, Rémi ^a,b,e,h  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^f UNIVERSITÉ DE SHERBROOKE   (Canada)

^g UNIVERSITY INSTITUTE OF GERIATRICS OF SHERBROOKE   (Canada)

^h Montreal Diabetes Research Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; TRIACYLGLYCEROL;

ANALYSIS OF VARIANCE; ARTICLE; BLOOD; BODY COMPOSITION; BODY MASS; ENERGY METABOLISM; FEMALE; FITNESS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HEALTH STATUS; HUMAN; INSULIN RESISTANCE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; OBESITY; PHOTON ABSORPTIOMETRY; POSTMENOPAUSE; SEDENTARY LIFESTYLE;

ABSORPTIOMETRY, PHOTON; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; C-REACTIVE PROTEIN; ENERGY METABOLISM; FEMALE; GLUCOSE CLAMP TECHNIQUE; HEALTH STATUS; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PHYSICAL FITNESS; POSTMENOPAUSE; SEDENTARY LIFESTYLE; TRIGLYCERIDES;

EID: 77951666576     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.364     Document Type: Article

References (34)

1. Ferrannini E. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr Rev 1998;19:477-490.
2. Thomas F, Bean K, Pannier B et al. Cardiovascular mortality in overweight subjects: the key role of associated risk factors. Hypertension 2005;46:654-659.
3. Yip J, Facchini FS, Reaven GM. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 1998;83:2773-2776.
4. Bonora E, Kiechl S, Willeit J et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998;47:1643-1649.
5. Ferrannini E, Natali A, Bell P et al. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest 1997;100:1166-1173.
6. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci C V, Leonetti F. Prevalence of uncomplicated obesity in an Italian obese population. Obes Res 2005;13:1116-1122.
7. McLaughlin T, Abbasi F, Lamendola C, Reaven G. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity. Arch Intern Med 2007;167:642-648.
8. Reaven G. All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals. Diab Vasc Dis Res 2005;2:105-112.
9. Karelis AD. Metabolically healthy but obese individuals. Lancet 2008;372:1281-1283.
10. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman E T. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004;89:2569-2575.
11. Sims EA. Are there persons who are obese, but metabolically healthy? Metab Clin Exp 2001;50:1499-1504.
12. Aguilar-Salinas CA, García EG, Robles L et al. High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab 2008;93:4075-4079.
13. Brochu M, Tchernof A, Dionne IJ et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 2001;86:1020-1025.
14. Karelis AD, Faraj M, Bastard JP et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005;90:4145-4150.
15. Lynch LA, O'Connell JM, Kwasnik AK et al. Are natural killer cells protecting the metabolically healthy obese patient? Obesity (Silver Spring) 2009;17:601-605.
16. Stefan N, Kantartzis K, Machann J et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008;168:1609-1616.
17. Meigs JB, Wilson PW, Fox CS et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006;91:2906-2912.
18. McLaughlin T, Allison G, Abbasi F, Lamendola C, Reaven G. Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metab Clin Exp 2004;53:495-499.
19. Wildman R P, Muntner P, Reynolds K et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008;168:1617-1624.
20. Karelis AD, Messier V, Brochu M, Rabasa-Lhoret R. Metabolically healthy but obese women: effect of an energy-restricted diet. Diabetologia 2008;51:1752-1754.
21. Rabasa-Lhoret R, Laville M. How to measure insulin sensitivity in clinical practice?. Diabetes Metab 2001;27:201-208.
22. Karelis AD, Rabasa-Lhoret R. Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals. Diabetes Metab 2008;34:183-184.
23. Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metab Clin North Am 2004;33:283-303. (Pubitemid 38680631)
24. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106: 3143-3421.
25. Faraj M, Messier L, Bastard JP et al. Apolipoprotein B: a predictor of inflammatory status in postmenopausal overweight and obese women. Diabetologia 2006;49:1637-1646.
26. Karelis AD, Fontaine J, Messier V et al. Psychosocial correlates of cardiorespiratory fitness and muscle strength in overweight and obese post-menopausal women: a MONET study. J Sports Sci 2008;26:935-940.
27. Karelis AD, Pasternyk SM, Messier L et al. Relationship between insulin sensitivity and the triglyceride-HDL-C ratio in overweight and obese postmenopausal women: a MONET study. Appl Physiol Nutr Metab 2007;32:1089-1096.
28. Messier V, Malita FM, Rabasa-Lhoret R, Brochu M, Karelis AD. Association of cardiorespiratory fitness with insulin sensitivity in overweight and obese postmenopausal women: a Montreal Ottawa New Emerging Team study. Metab Clin Exp 2008;57:1293-1298.
29. Weinsier RL, Nagy TR, Hunter GR et al. Do adaptive changes in metabolic rate favor weight regain in weight-reduced individuals? An examination of the set-point theory. Am J Clin Nutr 2000;72:1088-1094.
30. Schoeller DA, van Santen E. Measurement of energy expenditure in humans by doubly labeled water method. J Appl Physiol 1982;53:955-959.
31. Conus F, Allison DB, Rabasa-Lhoret R et al. Metabolic and behavioral characteristics of metabolically obese but normal-weight women. J Clin Endocrinol Metab 2004;89:5013-5020.
32. Marini MA, Succurro E, Frontoni S et al. Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. Diabetes Care 2007;30:2145-2147.
33. Forouhi NG, Harding AH, Allison M et al. Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia 2007;50:949-956.
34. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289-2304. (Pubitemid 41242486)